|
Post by lakers on Jan 9, 2016 21:52:26 GMT -5
Here is a great idea to help with marketing Afrezza All the current Afrezza users could start to make an appointment with a new endocrinologist(not with the intent to change from their current MD but just to educate a new MD) that is not currently writing scripts for Afrezza(checking Sam Finta's list of currently prescribing MD's). When they meet the new endocrinologist they could tell him/her about their success with Afrezza(show them improved A1c's or CGM readings) and ask them to please write a least one Afrezza script and see how their patient(s) do with the new drug. Just think if each current user were able to get one or two new scripts per week just think how that could add up over time. Hopefully Sam Finta would be able to pass this idea on to all the Afrezza users he knows.
By Teampt
My reply:
Brilliant! You could email/tweet to Sam and Eric. They need to change their Endos and ask the new ones write scripts for them first. This is a great way for Endos to see up close and personal the results, called targeted education, or guerilla mktg.
That's why DeSisto needs to listen.
|
|
|
Post by mnkdfann on Jan 9, 2016 22:13:07 GMT -5
"All the current Afrezza users could start to make an appointment with a new endocrinologist(not with the intent to change from their current MD but just to educate a new MD) that is not currently writing scripts for Afrezza ... When they meet the new endocrinologist they could tell him/her about their success with Afrezza ... and ask them to please write a least one Afrezza script and see how their patient(s) do with the new drug."
Am I missing something here? ... The plan is to make an appointment under false pretenses? The endocrinologist is expecting a new patient, and instead a self-appointed sales person shows up? Won't the endo be pissed at this? Or that this person prevented the endo from seeing a real patient? Presumably the endocrinologist isn't going to get paid for this 'educational' appointment either. Doesn't sound to me like a way to get an endo on board.
I think the idea needs a rethink.
|
|
|
Post by stevil on Jan 9, 2016 23:36:59 GMT -5
I don't really think it's that good of an idea either, unless they could somehow not push Afrezza onto the doc. Simply mentioning that they had already started Afrezza and wanted to continue taking it, then asking if it could be prescribed so they could stay on it would be the farthest they should go. Maybe asking them if they wouldn't mind researching it before the next appointment in case they had any questions for them... I can't imagine that it'd go over well if they walked into the office and started talking down to a physician to "educate" him/her. Most have egos and wouldn't appreciate that. Hopefully the doc will be curious and will ask questions. Under no circumstances would it be wise to ask the doc to prescribe for other patients.
To answer the other part of your question, this may not come as a cheap request. The billing code for a new patient is considerably higher than a follow up. The main reason behind the markup is a physician is supposed to do a complete history and physical whenever they take on a new patient, so the appointment length is considerably longer.
|
|
|
Post by ricguy on Jan 10, 2016 2:46:30 GMT -5
Here is a great idea to help with marketing Afrezza All the current Afrezza users could start to make an appointment with a new endocrinologist(not with the intent to change from their current MD but just to educate a new MD) that is not currently writing scripts for Afrezza(checking Sam Finta's list of currently prescribing MD's). When they meet the new endocrinologist they could tell him/her about their success with Afrezza(show them improved A1c's or CGM readings) and ask them to please write a least one Afrezza script and see how their patient(s) do with the new drug. Just think if each current user were able to get one or two new scripts per week just think how that could add up over time. Hopefully Sam Finta would be able to pass this idea on to all the Afrezza users he knows. By Teampt My reply: Brilliant! You could email/tweet to Sam and Eric. They need to change their Endos and ask the new ones write scripts for them first. This is a great way for Endos to see up close and personal the results, called targeted education, or guerilla mktg. That's why DeSisto needs to listen. lol I love how everyone volunteers these guys/gals like they have unlimited time and would even want and the capability to do this. Hey Spiro you up for this? If we are counting on this we're cooked.
|
|
|
Post by sportsrancho on Jan 10, 2016 5:59:57 GMT -5
Here is a great idea to help with marketing Afrezza All the current Afrezza users could start to make an appointment with a new endocrinologist(not with the intent to change from their current MD but just to educate a new MD) that is not currently writing scripts for Afrezza(checking Sam Finta's list of currently prescribing MD's). When they meet the new endocrinologist they could tell him/her about their success with Afrezza(show them improved A1c's or CGM readings) and ask them to please write a least one Afrezza script and see how their patient(s) do with the new drug. Just think if each current user were able to get one or two new scripts per week just think how that could add up over time. Hopefully Sam Finta would be able to pass this idea on to all the Afrezza users he knows. By Teampt My reply: Brilliant! You could email/tweet to Sam and Eric. They need to change their Endos and ask the new ones write scripts for them first. This is a great way for Endos to see up close and personal the results, called targeted education, or guerilla mktg. That's why DeSisto needs to listen. lol I love how everyone volunteers these guys/gals like they have unlimited time and would even want and the capability to do this. Hey Spiro you up for this? If we are counting on this we're cooked. Well I hope every shareholder has told their GP about Afrezza and Sam's results. If not it would be a great idea to pay him or her for an extra appointment and share:-)
|
|
|
Post by liane on Jan 10, 2016 6:48:41 GMT -5
Am I missing something here? ... The plan is to make an appointment under false pretenses? The endocrinologist is expecting a new patient, and instead a self-appointed sales person shows up? Won't the endo be pissed at this? Or that this person prevented the endo from seeing a real patient? Presumably the endocrinologist isn't going to get paid for this 'educational' appointment either. Doesn't sound to me like a way to get an endo on board. I think the idea needs a rethink. The 1st part of your post - I agree totally. As a physician, I can attest we invest a lot of time and energy in each new patient. Where you are incorrect is regarding payment. There are actually 5 levels that can be coded for a new patient and 5 levels for an established patient. The reimbursements are higher for new patient visits to reflect the additional time and complexity of the visit. But if a "new patient" shows up with the intent of trying to educate the physician and not with the intent of having that physician manage his/her care, then the physician would likely have to code the visit 1 level lower than usual and would be reimbursed less. I've actually had something along this line happen to me. A very "odd" new patient showed up, for a condition not even related to my scope of practice (the office staff could not have known to weed him out prior to the visit). He primarily wanted to pick my brain on tangentially related topics, and would not even let me examine him. So serious downcode on the visit. But I was pissed in that I could have seen 2 established patients in that same time frame and really been of help to them.
|
|
|
Post by slugworth008 on Jan 10, 2016 8:47:51 GMT -5
Here is a great idea to help with marketing Afrezza All the current Afrezza users could start to make an appointment with a new endocrinologist(not with the intent to change from their current MD but just to educate a new MD) that is not currently writing scripts for Afrezza(checking Sam Finta's list of currently prescribing MD's). When they meet the new endocrinologist they could tell him/her about their success with Afrezza(show them improved A1c's or CGM readings) and ask them to please write a least one Afrezza script and see how their patient(s) do with the new drug. Just think if each current user were able to get one or two new scripts per week just think how that could add up over time. Hopefully Sam Finta would be able to pass this idea on to all the Afrezza users he knows. By Teampt My reply: Brilliant! You could email/tweet to Sam and Eric. They need to change their Endos and ask the new ones write scripts for them first. This is a great way for Endos to see up close and personal the results, called targeted education, or guerilla mktg. That's why DeSisto needs to listen. Here's the basic problem - We are on a message board discussing how MNKD (or some BP) should market Afrezza. That's MNKD's job - An integrated marketing campaign directly to endo's and PA's that combines direct mail and PURLS with an accompanying informational microsite could be done in phases, reviewed for responses/activity, adjusted and continued. 500K would cover this easily. The LeadGen company I work for could do this - I drive our Integrated Marketing solutions and would be happy to run this campaign. We acquire and append data lists every day. MNKD could hire Sam and Peakabull - "Hello my name is Sam Finta and here's my AiC numbers after "X" weeks on Afrezza" ect... The simple fact that NO marketing like this has taken place is maddening and laughable at the same time. Now that I think about it...I'm going to make a sales call to MNKD.
|
|
|
Post by kball on Jan 10, 2016 8:53:47 GMT -5
Here is a great idea to help with marketing Afrezza All the current Afrezza users could start to make an appointment with a new endocrinologist(not with the intent to change from their current MD but just to educate a new MD) that is not currently writing scripts for Afrezza(checking Sam Finta's list of currently prescribing MD's). When they meet the new endocrinologist they could tell him/her about their success with Afrezza(show them improved A1c's or CGM readings) and ask them to please write a least one Afrezza script and see how their patient(s) do with the new drug. Just think if each current user were able to get one or two new scripts per week just think how that could add up over time. Hopefully Sam Finta would be able to pass this idea on to all the Afrezza users he knows. By Teampt My reply: Brilliant! You could email/tweet to Sam and Eric. They need to change their Endos and ask the new ones write scripts for them first. This is a great way for Endos to see up close and personal the results, called targeted education, or guerilla mktg. That's why DeSisto needs to listen. lol I love how everyone volunteers these guys/gals like they have unlimited time and would even want and the capability to do this. Hey Spiro you up for this? If we are counting on this we're cooked.What i thought as i read the initial post. Also insulting and somewhat insane. What's next? How about a free puppy on your first refill? My feeling is we're cooked anyways, and all of us will have varying amounts of tax loss carry forwards. Some huge. The lucky ones a lot less.
|
|
|
Post by sportsrancho on Jan 10, 2016 9:17:36 GMT -5
If the boat you paid for a ride in sprung a leak would you just sit there because you paid for the ride? A lot of good ideas are coming from shareholders. I wouldn't count MNKD out just yet!
|
|
nsmyth
Lab Rat
Posts: 43
Sentiment: Long
|
Post by nsmyth on Jan 10, 2016 9:21:09 GMT -5
thinking along similar lines regarding a few of the evangelists. create an organization thats purpose is to teach people how to manage their diabetes through the techniques Sam and team are touting. will have to raise some funds to do this. but the org won't be able to sell any drug but will teach people how to manage the diabetes using afrezza. Folks will still have to go to doctors to get prescribed but will of course have this database of prescribing docs to share. the org won't be held back from telling the truth on the superiority of Afrezza because they are not employed by Mannkind and they are not prescribing. its a coaching organization. Will advertise as well with statements from many of the success stories.
|
|
|
Post by vestful on Jan 10, 2016 11:34:23 GMT -5
Only half serious about this because the timing isn't right but... How about a TED Talk from Duane or Sam? Make it more about diabetes but sprinkle in some afrezza/new strategies.
|
|
|
Post by mnkdfann on Jan 10, 2016 12:24:56 GMT -5
Am I missing something here? ... The plan is to make an appointment under false pretenses? The endocrinologist is expecting a new patient, and instead a self-appointed sales person shows up? Won't the endo be pissed at this? Or that this person prevented the endo from seeing a real patient? Presumably the endocrinologist isn't going to get paid for this 'educational' appointment either. Doesn't sound to me like a way to get an endo on board. I think the idea needs a rethink. The 1st part of your post - I agree totally. As a physician, I can attest we invest a lot of time and energy in each new patient. Where you are incorrect is regarding payment. There are actually 5 levels that can be coded for a new patient and 5 levels for an established patient. The reimbursements are higher for new patient visits to reflect the additional time and complexity of the visit. But if a "new patient" shows up with the intent of trying to educate the physician and not with the intent of having that physician manage his/her care, then the physician would likely have to code the visit 1 level lower than usual and would be reimbursed less. I've actually had something along this line happen to me. A very "odd" new patient showed up, for a condition not even related to my scope of practice (the office staff could not have known to weed him out prior to the visit). He primarily wanted to pick my brain on tangentially related topics, and would not even let me examine him. So serious downcode on the visit. But I was pissed in that I could have seen 2 established patients in that same time frame and really been of help to them. Your example is a bit different, I think, in that the person who showed up is at least talking about some medical issue and wants your advice. In the ambush of a random endocrinologist situation I was commenting on I would have thought the visit would be unbillable. I was comparing it mentally to someone booking an appointment, then showing up to talk you into buying a new Lexus. At the very least, even if that is billable, I would have thought that the insurance system paying for that person's visit wouldn't be entirely pleased.
|
|
|
Post by ricguy on Jan 10, 2016 14:17:54 GMT -5
If the boat you paid for a ride in sprung a leak would you just sit there because you paid for the ride? A lot of good ideas are coming from shareholders. I wouldn't count MNKD out just yet! If the boat was 3/4 under water like we are now I would of had the women and children out on life boats, life vests and the men jumping ship already aka dumping shares. I guess I'm the captain of the ship because I'm still holding and going down with it.
|
|
|
Post by ricguy on Jan 10, 2016 14:38:43 GMT -5
lol I love how everyone volunteers these guys/gals like they have unlimited time and would even want and the capability to do this. Hey Spiro you up for this? If we are counting on this we're cooked. Well I hope every shareholder has told their GP about Afrezza and Sam's results. If not it would be a great idea to pay him or her for an extra appointment and share:-) Yep, you just made my point. Here is my experience with my GP (cliff notes)- Me-"Hey Doc want to tell you about this new product called Afrezza" Conversation goes on for 10 minutes (he has heard of it). I begin explaining Sam's and others great experience that can not be argued or debated. Doc is very interested (I've been with my GP for 30+ years so we have pretty good communication and talk about many things, medicine, world, sports, family, stocks, politics etc). Doc begins to ask me more questions outside of user experience, aka company that owns it, how long on the market, who is marketing/selling it. We get to the point where I tell him oh the guys that were selling it pulled out after it being on the market for about a year or so. Doc-"Oh really why?" Me-"Well in my opinion they weren't trying to sell it but per SNY the product wouldn't sell." Doc-"So who is selling it now, is anyone?" Me-"They are looking for a new partner or might go it alone, we really don't know yet but it is still available" I explain the time period between SNY and MNKD (transition) Doc-"So how does this impact MNKD and the future of Afrezza" I then go into TS etc and then I tell him that the financials and the survival of the company and the future of Afrezza are uncertain right now, we just don't know what is going to happen. Naturally the Doc will be looking to spread the word to all Endos after this outstanding conversation and outlook ;-) User experience will not be enough, again if we are just counting on that we are cooked. MNKD the company needs to get their house in order quick. We are on the same side here, I really want MNKD to pull this out but the sentence above is my belief.
|
|
|
Post by bill on Jan 10, 2016 15:14:30 GMT -5
Here's another marketing idea that I even passed on to MNKD...
How about expanding the Matt Bendall video technique and create one that shows 3 people eating a meal, each hooked up to a CGM. One person is non-diabetic, one is diabetic and will inject a conventional meal-time insulin, and one is diabetic and will inhale Afrezza. Compress the time and show what happens to the blood glucose levels across those 3 people and let Afrezza sell itself (assuming the results are as we might expect). The voice over explain what a CGM records and why it's important, and would include pointing out that Afrezza is the only product that uses the same monomer insulin as produced by a fully functioning pancreas. And, instead of injecting it you "just breathe."
You could create a database with more people, more meal types, include A1c comparison, etc., but I think the video might be kind of compelling...
|
|